The US Food and Drug Administration (FDA) has accepted and granted Priority Review to a Biologics License Application (BLA) submitted by Alexion, a unit of AstraZeneca (NASDAQ: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results